Key Findings:  BCP alleviates ischemic brain damage potentially by inhibiting necroptotic neuronal death and inflammatory response. This study suggests a novel application for BCP as a neuroprotective agent.
Type of Study:  Animal Study
Study Result:  Positive
Research Location(s):  China, United States
Year of Pub:  2017
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  ß-Caryophyllene
Receptors Studied:  CB2
Ligands Studied:  Anti-inflammatory cytokines, Pro-inflammatory cytokines
Dosage: BCP (8, 24, 72 mg/kg, ip.)
Route of Administration:  Injection
Citation:  Yang M, et al. Neuroprotective Effect of β-Caryophyllene on Cerebral Ischemia-Reperfusion Injury via Regulation of Necroptotic Neuronal Death and Inflammation: In Vivo and in Vitro. Front Neurosci. 2017; 11:583. doi: 10.3389/fnins.2017.00583
Authors:  Yang M, Lv Y, Tian X, Lou J, An R, Zhang Q, Li M, Xu L, Dong Z